EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted and Biosafe Delivery of Spermidine to Ameliorate Foreign Body Responses After Synthetic Vascular Graft Implantation In Vivo

Jiahui Wu, Jie Fang, Shaofei Wu, Guosheng Fu, Jing Zhao, Jiayin Fu, Wenbin Zhang

Small Structures · 2026-11 · 7 (11)

DOI: 10.1002/sstr.70659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Structures, online erschienen am 05.11.2026. Verfasst von Jiahui Wu und 6 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Science and Technology Program of Zhejiang Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular grafts are crucial for treating cardiovascular diseases, but their clinical application is limited by poor regeneration due to foreign body reactions. Spermidine (SPD), a natural polyamine with anti‐inflammatory and antioxidant properties, shows promise in inhibiting inflammation in vitro but is challenged by the lack of targeting ability and high cytotoxicity in vivo. To address these issues, we developed platelet membrane fragments (PMFs)‐modified lipid nanoparticles (PLNPs) for targeted delivery of SPD (PLNP‐SPD) by adventitial administration to inflamed tissues around poly(ε‐caprolactone) (PCL) vascular grafts. PLNP‐SPD showed a spherical structure with integrated PMFs. In vitro, PLNP‐SPD selectively bound to inflamed macrophages via P‐selectin/PSGL‐1 interactions, promoted SPD internalization by macrophages through membrane fusion, and suppressed macrophage M1 polarization. In vivo, adventitial delivery of PLNP‐SPD surrounding PCL vascular grafts demonstrated selective accumulation in macrophages, reduced inflammation, and thus improved vascular regeneration. PLNP‐SPD also exhibited excellent biosafety with minimal systemic toxicity. This study highlights PLNP‐SPD as a novel nanoplatform for targeted SPD delivery in vivo, which offers a promising strategy to mitigate foreign body reactions caused by graft implantation and promote vascular regeneration.

Förderung

  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Science and Technology Program of Zhejiang Province

Zitieren

APA

Wu, J., Fang, J., Wu, S., Fu, G., Zhao, J., Fu, J., & Zhang, W. (2026). Targeted and Biosafe Delivery of Spermidine to Ameliorate Foreign Body Responses After Synthetic Vascular Graft Implantation In Vivo. Small Structures, 7(11). https://doi.org/10.1002/sstr.70659

Vancouver

Wu J, Fang J, Wu S, Fu G, Zhao J, Fu J, et al. Targeted and Biosafe Delivery of Spermidine to Ameliorate Foreign Body Responses After Synthetic Vascular Graft Implantation In Vivo. Small Structures. 2026;7(11). doi:10.1002/sstr.70659

BibTeX
@article{Wu2026,
  author = {Wu, Jiahui and Fang, Jie and Wu, Shaofei and Fu, Guosheng and Zhao, Jing and Fu, Jiayin and Zhang, Wenbin},
  title = {Targeted and Biosafe Delivery of Spermidine to Ameliorate Foreign Body Responses After Synthetic Vascular Graft Implantation In Vivo},
  journal = {Small Structures},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/sstr.70659}
}
Kostenlos starten →